COMPANY

Tulavi Therapeutics

HQ: Los Gatos, CA source · tulavi.com ↗ · West Coast

Keywords: hydrogel Peripheral Nerve Injuries Nerve Cap

Location: Los Gatos, CA · source · Oct 15, 2026

Profile checked Oct 10, 2026

Timeline

May 6, 2026 Trial start —: Continuous Observational Monitoring Program for Allay™ Hydrogel Cap Safety and Success Study source ↗
Sep 29, 2025 FDA FDA 510(k) clearance: allay Nerve Cap (TL5515-1); allay Nerve Cap (TL5515-2); Delivery Tips (TL-7627) — K252051, Sep 29, 2025. Applicant at approval: Tulavi Therapeutics, Inc. source ↗

Jan 1, 2029 (ESTIMATED) · · Continuous Observational Monitoring Program for Allay™ Hydrogel Cap Safety and Success Study · NCT07246980

Estimated primary completion per ClinicalTrials.gov. Dates move.

Record	Title	Phase	Status	Start	Primary completion
NCT07246980	Continuous Observational Monitoring Program for Allay™ Hydrogel Cap Safety and Success Study	Not listed	Recruiting	May 6, 2026	Jan 1, 2029 (estimated)

Sep 29, 2025 FDA 510(k) clearance: allay Nerve Cap (TL5515-1); allay Nerve Cap (TL5515-2); Delivery Tips (TL-7627) — K252051, Sep 29, 2025. Applicant at approval: Tulavi Therapeutics, Inc. source ↗

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-12